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Reducing sugars (e.g., glucose, fructose, galactose, mannose, ribose) and certain other
carbohydrate relatives (e.g., ascorbic acid) are inherently reactive toward nucleophiles
(Maillard reaction) (1). Glucose can react with a free amino group (nucleophilic nitrogen
base), such as an -amino group of protein lysine residue, to form an adduct commonly
referred to a Schiff base. Formation of the Schiff base from sugar and amine is a fast and
highly reversible reaction. Formation of an Amadori product (AP) from the Schiff base is
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Non-enzymatic glycation as the chain reaction between
reducing sugars and free amino groups of proteins has
been shown to correlate with physiological ageing and
severity of diabetes. The process involves oxidative steps
(glycoxidation). In this paper, the effect of D-fructose as
a reactive sugar on aspartate aminotransferase (AST) as
a model protein was monitored by measurements of the
enzyme activity and formation of fluorescent advanced
glycation end products (AGEs). Change in the AST ac-
tivity was considered as a measure of the overall protein
damage caused by glycation, and total AGEs and pentosi-
dine represent, at least partly, the formation of glycoxi-
dation products. Catalytic activity of AST in an incubation
mixture containing D-fructose (50 mmol L–1), decreased
compared to control values to 42% (p < 0.05) and to 11%
(p < 0.05) on the 5th and on 21st day of incubation, re-
spectively. In the presence of fructose, total fluorescent
AGEs concentration was significantly higher since 5th day
of incubation (110%, p < 0.05) and the fluorescent pen-
tosidine concentration from 15th day of incubation (117%,
p < 0.05) compared to control values, respectively. Cata-
lytic activity of AST clearly and quantitatively demon-
strated functional changes in the enzyme molecule caused
by structural modifications initiated by fructose, while the
evaluation of AGE formation and especially that of pen-
tosidine by fluorescence measurement was less reliable.
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slow but it is much faster than the reverse reaction, so the Amadori glycation tends to
accumulate in proteins. The later stage, complex pigments and crosslinks have come to
be known as advanced glycation end products (AGEs). AGEs constitute a heterogenous
group of irreversible adducts that were originally characterized by their yellow-brown
colour. It is known that these irreversible products include many protein-protein cros-
slinking structures as well as various non-crosslinked structures. Many, but not all of these
products incorporate ultraviolet-visible and/or fluorescent chromophores (2).
There are three routes to producing AGEs: (i) via the autooxidative pathway (sugar
gives reactive products by autooxidation) (3), (ii) via conventional Amadori rearrange-
ment (4), and (iii) from the Schiff base (5). Reactive oxygen species: O2, H2O2, OH
(ROS) may contribute to these reactions, which require trace levels of catalytic redox-ac-
tive transition metal ions. The process includes also oxidative steps and is therefore cal-
led glycoxidation (6).
Both glycation and oxidation reactions lead to the formation of AGEs, including the
subclass of AGEs known as glycoxidation products (GOPs): pentosidine and N-(carbo-
xymethyl)-lysine (CML). The production of AGEs is accelerated by oxidative stress with-
out the presence of sugar. There is evidence for a rise of pentosidine and CML from
ascorbic acid (9).
Glycoxidation is considered to cause gradual deterioration in the structure and func-
tion of tissue proteins and to contribute to the pathophysiology of normal ageing. This
post-translational modification of proteins and other macromolecules with amino groups
is accelerated by hyperglycemia in diabetes, by hyperlipidemia in atherosclerosis, and
by oxidative stress in other chronic diseases including Alzheimer’s and Parkinson’s dis-
ease (8–10). Furthermore, in diabetic patients with impaired renal function, food-derived
AGEs with crosslinking activity can accumulate in serum to a significant degree, imply-
ing that normal kidney function is important for protection against dietary AGEs (11,
12). Another source of orally uptaken AGEs seems to be smoking, since significantly in-
creased serum AGE levels have been observed in diabetic smokers compared to diabetic
non-smokers (13).
It means that the level of AGE proteins reflects the kinetic balance of two opposite
processes: the rate of AGE compounds formation and the rate of their degradation and
elimination (14). This fact indicates the possibility of therapeutic intervention against
AGEs by stimulation of their degradation or by inhibition of their formation (15). Fur-
ther possibilities of therapy come from the knowledge of the character of protein modifi-
cations caused by glycoxidation (changes in their physico-chemical properties, such as
solubility, isoelectric point, charge, ability of crosslinking, resistance to denaturation, etc.) (2).
Giardino et al. (16) demonstrated by in vitro experiments that one-week incubation
of endothelial cells in the presence of a high glucose concentration resulted in a 13.8-fold
increase in the intracellular AGE-content. In parallel, the mitogenic activity of endothe-
lial cells cultivated at a high glucose concentration decreased markedly. The observed
loss in mitogenic activity was due to the post-translational modification of the basic fi-
broblast growth factor (bFGF) by AGE, the major AGE-modification in endothelial cells.
In our laboratory, a model of aspartate aminotransferase or alanine aminotransferase
as a protein and D-fructose as the glycating agent was developed and applied in several
glycation studies (17, 18), in which enzyme activity served as the criterion of protein
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modification. The objective of this study is to show the possible applicability of this mo-
del for monitoring the oxidation part of the glycation process in the presence of fructose
through measurements of fluorescent AGEs and pentosidine.
EXPERIMENTAL
Chemicals
In vitro glycation was studied with aspartate aminotransferase (AST, EC 2.6.1.1), cy-
tosolic enzyme from porcine heart, suspension in ammonium sulphate (SERVA Electro-
phoresis GmbH, Germany and Roche Diagnostics GmbH, Germany). Fructose was used
as the glycating agent (Sigma-Aldrich Co. Ltd., USA). Other chemicals used, such as
NaH2PO42H2O, Na2HPO4 12H2O, NaN3, and uric acid, were of analytical grade. The
reagent kit for enzyme activity measurements was purchased from Roche Diagnostics
GmbH, Germany. Albumin, Bovine Fraction V, 96–99%, was used as the reference sub-
stance for fluorescence measurements (Sigma Chemical Company, USA).
Buffer, enzyme and fructose preparation
Phosphate buffer (0.1 mol L–1, pH 7.4) with 0.05% sodium azide was used for the
preparation of incubation mixtures.
Suspension of AST was centrifuged for 20 min at 5000 rpm (at 4 C), the superna-
tant was removed and the protein pellet was reconstituted in 0.1 mol L–1 phosphate buf-
fer pH 7.4 to yield the stock solution with the enzyme concentration of 2.66 mg mL–1.
100 mmol L–1 stock solution of fructose was prepared in 0.1 mol L–1 phosphate buf-
fer pH 7.4 with 0.05% sodium azide.
Preparation of incubation mixtures
Incubation mixtures for investigation of the catalytic activity of AST and for the
study of AGEs and pentosidine formation were prepared according to Table I.
Final concentrations of substances in the incubation mixture for activity of AST were
as follows: 1.33 mg mL–1 AST and 50 mmol L–1 fructose. All samples were incubated for
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AST 0.208 0.208 – 0.416
AST + fructose 0.208 – 0.208 0.416
AGEs and pentosidine formation
AST 1.56 1.56 – 3.12
AST + fructose 1.56 – 1.56 3.12
up to 21 days at 37 C, and enzyme activity was measured in triplicate on days: 0, 1, 5, 8,
12, 15, and 21. Control values represent the catalytic activity of AST incubated without
fructose for the same time.
Final concentrations of substances in the incubation mixture for AGEs and pentosi-
dine formation were as follows: 1.33 mg mL–1 AST and 50 mmol L–1 fructose. All samples
were incubated for up to 15 days at 37 C. The amount of 600 L of each sample was
taken on days: 0, 1, 3, 5, and 15 and stored in a freezer at –80 C. Fluorescence was mea-
sured in triplicate at the end of the experiment.
Catalytic activity measurement
AST catalytic activity was measured by the IFCC-recommended method (19), on an
automated clinical chemistry analyzer Hitachi 917 (Japan).
Fluorescence measurements
The effects of glycation and glycoxidation were determined from the specific fluo-
rescence intensity resulting from pentosidine and total AGEs level. Fluorescence mea-
surements of glycated AST samples were monitored using a luminescence spectrometer
Perkin-Elmer LS 50B (UK) at excitation (ex) and emission (em) wavelengths of 335/385
nm (optimum for AGE biomarker pentosidine) and 370/440 nm for the total AGEs level.
Bovine serum albumin (BSA) was used as the reference substance in a concentration of 1
mg mL–1. Relative fluorescence of pentosidine or total AGEs was expressed in arbitrary
units per mg of protein (1 AU corresponding to the fluorescence of 1 mg mL–1of BSA).
Statistics
Differences between means were assessed using the Mann-Whitney rank sum-test.
The values p < 0.05 were considered statistically significant. SigmaStat program for Win-
dows, version 2.0, Jandel Corporation (USA) was used for statistical analysis.
RESULTS AND DISCUSSION
In vitro glycation and glycoxidation were studied with AST. The enzyme was cho-
sen as a model protein for its availability in a highly purified stable form (cytosolic por-
cine heart enzyme) and because of the presence of a few lysine residues in the molecule,
which can undergo the glycoxidation process. Furthermore, Okada et al. (20) considered
glycation to be one of the possible mechanisms for the existing variants of this enzyme
in animal cells.
Effect of glycation on catalytic activity of AST
Effect of 50 mmol L–1 fructose as the glycating agent on the catalytic activity of AST
was monitored for 21 days at 37 °C. Effect of glycation on lowering the enzyme activity
was evident from the beginning of the incubation with fructose. The most rapid decrease
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occurred from the 1st to the 5th day. Catalytic activity of AST decreased to 84% on the
first day and to 42% (p < 0.05) on the fifth day compared to the control value, represent-
ing catalytic activity of AST incubated without fructose for the same time. Enzyme activ-
ity continued to decrease to 23% on the 12th day, and to 11% on the 21st (Table II).
In this study, the authors’ intention was to monitor glycation and glycoxidation pro-
cesses through the changes in catalytic activity of AST as well as by detection of its final
products (total AGEs and pentosidine). Due to previous results, which indicated that
glucose or glucose-6-phosphate in vitro showed weak or no significant effects on the cat-
alytic activity of AST and that the Heyns product derived from fructose (ketoses) was
considerably more reactive than the Amadori product, fructose was used as the glycat-
ing agent (18, 21, 22). Protein glycation by fructose (fructation) was also suggested to a
major determinant in diabetes complications, especially in cells with a hyperactive sor-
bitol pathway (23). Another advantage of the use of fructose as the glycating agent in
this study was that the process of fructation is probably connected with a higher rate of
AGEs production than the process of protein modification by glucose. Although fluores-
cence is a useful marker for detection of AGE formation, the fluorescent AGE crosslinks
(represented by pentosidine) are thought to account for only one percent or less of the
total crosslinking structures formed under physiological conditions (24). Thus, the major
AGE structures responsible for protein-protein crosslinking in vivo are the non-fluores-
cent structures that have not yet been conclusively identified.
Effect of fructose on the production of AGEs
Table III shows the effect of fructose on the total AGEs formation during fifteen
days of enzyme incubation at 37 °C. Compared to the control values, the fluorescence
measured at exc 370 nm/em 440 nm was significantly higher in samples with fructose
on the 5th (110%, p < 0.05) and the 15th day (145%, p < 0.05).
Table IV shows the effect of fructose on pentosidine formation during fifteen days
of enzyme incubation at 37 °C. Compared to the control values, the fluorescence mea-
sured at exc 335 nm/em 385 nm was significantly higher in samples with fructose on
the 15th day (117%, p < 0.05).
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0 1 5 8 12 15 21
AST 6.09±0.38 5.29±0.34 4.33±0.17 6.59±0.03 5.47±0.06 6.83±0.15 5.23±0.58
AST + 50mmol L–1
fructose
5.94±0.23 4.43±0.34 1.82±0.41c 2.55±0.13c 1.26±0.06c 1.43±0.08c 0.58±0.02c
a Enzyme concentration: 1.33 mg mL–1.
b Average activity ± SD, n = 3.
c Significantly different from the samples without fructose measured on the same day (p < 0.05).
According to the results, fructose induced a decrease in the catalytic activity of AST
throughout the study period. A statistically significant decrease was observed even on
the fifth day of incubation with fructose, while a substantial increase in fluorescence as
the measure of total AGEs and pentosine formation was observed after 15 days.
CONCLUSIONS
This study presents the results of the measurements of fluorescent AGEs as repre-
sentatives of the complex glycoxidating process. We can conclude that the proposed mo-
del is efficient enough for the investigation of AST modification by fructose using the
measurement of the catalytic activity of the enzyme. In our future experiments with na-
tural antioxidants, we are going to improve the AST-fructose model by introducing the
transition metal ions (25, 26), which should support the oxidation part of the glycation
process.
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Table III. Fluorescence of glycated AST expressed as total AGEs (exc 370 nm/em 440 nm)
Incubation
mixturea
Fluorescence (AU per mg of protein)b,c
Time (day)
0 1 3 5 15
AST 2.153±0.075 2.231±0.015 2.304±0.034 2.186±0.051 2.410±0.030
AST + 50 mmol L–1
fructose
2.128±0.015 2.212±0.052 2.387±0.011 2.465±0.045d 3.511±0.071d
a Enzyme concentration: 1.33 mg mL–1.
b 1 AU corresponding to the fluorescence of 1 mg BSA mL–1.
c Average fluorescence ± SD, n = 3.
d Significantly different from the samples without fructose measured on the same day (p  0.05).
Table IV. Fluorescence of glycated AST expressed as pentosidine (exc 335 nm/em385 nm)
Incubation
mixturea
Fluorescence (AU/mg per mg of protein)b,c
Time (day)
0 1 3 5 15
AST 2.472±0.313 2.404±0.073 2.513±0.120 3.315±0.092 3.733±0.127
AST + 50 mmol L–1
fructose
2.323±0.080 2.325±0.074 2.459±0.036 3.484±0.247d 4.483±0.337d
a Enzyme concentration: 1.33 mg mL–1.
b 1 AU corresponding to the fluorescence of 1 mg BSA mL–1.
c Average fluorescence ± SD, n = 3.
d Significantly different from the samples without fructose measured on the same day (p  0.05).
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S A @ E T A K
Kataliti~ka aktivnost i stvaranje AGE-produkata u modelu glikoksidacije AST
D-fruktozom in vitro
IVA BOU[OVÁ, DANKA VUKASOVI], DUBRAVKA JURETI], VLADIMÍR PALI^KA i JAROSLAV DR[ATA
Neenzimska glikacija je proces kojim se reduciraju}i {e}eri kovalentnim vezama po-
vezuju s amino skupinama proteina, bez posredovanja enzima. Taj proces dijelom je i
oksidativan pa se ~esto naziva glikooksidacija. Kona~ni produkti glikacije (AGE) nastaju
polimerizacijom mnogih intermedijarnih produkata. U ovom radu, pra}en je u in vitro
uvjetima, mjerenjem kataliti~ke aktivnosti enzima i fluorescencije nastalih ukupnih AGE
produkata i pentozidina, utjecaj D-fruktoze kao reaktivnog {e}era na aspartat aminotrans-
ferazu (EC 2.6.1.1.) kao modelni protein. Promjena kataliti~ke aktivnosti enzima pokaza-
telj je promijenjene funkcije proteina glikacijom dok je intenzitet fluorescencije ukupnih
AGE produkata i pentozidina samo djelomi~an pokazatelj glikoksidacijskih promjena.
Kataliti~ka aktivnost AST izmjerena IFCC preporu~enom metodom u inkubacijskoj smjesi
koja je sadr`avala 50 mmol L–1 fruktoze, smanjena je na 42% (p  0.05) petog dana, te na
11% (p  0.05) dvadeset i prvog dana. Statisti~ki su zna~ajne razlike u kataliti~koj aktiv-
nosti enzima inkubiranog sa i bez fruktoze ve} nakon petog dana. Stvaranje ukupnih
AGE produkata i pentozidina statisti~ki je zna~ajno nakon pet, odnosno 15 dana inku-
bacije enzima s fruktozom. Kataliti~ka aktivnost enzima jasno ukazuje na funkcionalne
promjene uzrokovane glikiranjem, dok je evaluacija stvaranja ukupnih AGE produkata,
a pogotovo pentozidina, mjerenjem fluorescencije manje pouzdan pokazatelj promjena.
Klju~ne rije~i: neenzimska glikacija, glikoksidacija, aspartat aminotransferaza, krajnji produkti gli-
kacije, pentozidin
Faculty of Pharmacy and Medical Faculty, Hradec Králové, Czech Republic
Farmaceutsko-biokemijski fakultet, Zagreb
114
I. Bou{ová et al.: Enzyme activity and AGE formation in a model of AST glycoxidation by D-fructose in vitro, Acta Pharm. 55 (2005)
107–114.
